Investing.com - Champions Oncology reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Champions Oncology announced earnings per share of $-0.02 on revenue of $13.75M. Analysts polled by Investing.com EPS of $0.0167 on revenue of $13.19M.
Champions Oncology 's are down 10% and is trading at $7.520 , still down 29.98% from its 52 week high of $10.74 set on Friday, September 17, 2021.
Champions Oncology follows other major Healthcare sector earnings this month
Champions Oncology's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, EPS of $1.12 on revenue of $7.22B.
Merck ADR had beat expectations on Friday with third quarter EPS of $0.5392 on revenue of $5.69B, for EPS of $0.5165 on revenue of $5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar